PAK1 and pancreatic ductal adenocarcinoma: Recently, a study found in pancreatic ductal adenocarcinoma (PDA), PAK1 knockout improved the number of CD4+ and CD8+ T cells and inhibited the activation of pancreatic stellate cells (PSCs) 62.